Soh et al. found that nuclear localization of GST-π was associated with both inherent and acquired drug resistance in gynecological cancers, which indicated that GST-π in malignant cells may be a useful predictor and may contribute to anti-cancer drug selection [18]. Here, GSTP1 is linked to female reproductive organ cancer.